Have a feature idea you'd love to see implemented?
Let us know!
AMRN Amarin Corp Plc
Price (delayed)
$0.5931
Market cap
$243.87M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.09
Enterprise value
$35.52M
Amarin is a rapidly growing, innovative pharmaceutical company leading a new paradigm in cardiovascular disease management. From its scientific research foundation to its focus on clinical trials, and now its
Highlights
AMRN's net income is up by 36% from the previous quarter and by 12% YoY
AMRN's quick ratio is up by 16% year-on-year
The company's EPS rose by 31% QoQ but it fell by 13% YoY
AMRN's gross margin is down by 10% year-on-year but it is up by 4.8% since the previous quarter
Amarin's gross profit has decreased by 31% YoY
The revenue is down by 24% year-on-year and by 4.6% since the previous quarter
Key stats
What are the main financial stats of AMRN
Market
Valuations
Earnings
Shares outstanding
411.17M
Market cap
$243.87M
Enterprise value
$35.52M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.44
Price to sales (P/S)
0.92
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.13
Revenue
$264.78M
EBIT
-$28.45M
EBITDA
-$25.46M
Free cash flow
-$9.18M
Per share
Balance sheet
Liquidity
EPS
-$0.09
Free cash flow per share
-$0.02
Book value per share
$1.34
Revenue per share
$0.64
TBVPS
$1.9
Total assets
$799.86M
Total liabilities
$247.98M
Debt
$8.1M
Equity
$551.88M
Working capital
$471.3M
Debt to equity
0.01
Current ratio
3.04
Quick ratio
1.87
Net debt/EBITDA
8.19
Margins
Efficiency
Dividend
EBITDA margin
-9.6%
Gross margin
56.5%
Net margin
-12.7%
Operating margin
-15.3%
Return on assets
-4.1%
Return on equity
-6.1%
Return on invested capital
-8.5%
Return on capital employed
-5%
Return on sales
-10.7%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
AMRN stock price
How has the Amarin stock price performed over time
Intraday
-1.8%
1 week
1.68%
1 month
-5.18%
1 year
-30.53%
YTD
-31.83%
QTD
-5.39%
Financial performance
How have Amarin's revenue and profit performed over time
Revenue
$264.78M
Gross profit
$149.62M
Operating income
-$40.4M
Net income
-$33.52M
Gross margin
56.5%
Net margin
-12.7%
AMRN's operating income is up by 37% since the previous quarter and by 28% year-on-year
AMRN's net income is up by 36% from the previous quarter and by 12% YoY
AMRN's operating margin is up by 33% since the previous quarter and by 6% year-on-year
AMRN's net margin is up by 33% since the previous quarter but it is down by 14% year-on-year
Growth
What is Amarin's growth rate over time
Valuation
What is Amarin stock price valuation
P/E
N/A
P/B
0.44
P/S
0.92
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.13
The company's EPS rose by 31% QoQ but it fell by 13% YoY
AMRN's P/B is 82% below its 5-year quarterly average of 2.4 and 27% below its last 4 quarters average of 0.6
The equity has declined by 3% year-on-year
The P/S is 69% less than the 5-year quarterly average of 3.0 and 23% less than the last 4 quarters average of 1.2
The revenue is down by 24% year-on-year and by 4.6% since the previous quarter
Efficiency
How efficient is Amarin business performance
The ROIC has increased by 42% QoQ and by 33% YoY
The company's return on sales rose by 40% QoQ and by 22% YoY
AMRN's ROE is up by 36% from the previous quarter and by 8% YoY
Amarin's ROA has increased by 35% from the previous quarter and by 7% YoY
Dividends
What is AMRN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for AMRN.
Financial health
How did Amarin financials performed over time
The current ratio has grown by 16% YoY
AMRN's quick ratio is up by 16% year-on-year
AMRN's debt is 99% smaller than its equity
Amarin's debt to equity has plunged by 50% from the previous quarter and by 50% YoY
AMRN's debt is down by 14% year-on-year and by 3.5% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.